Angi Inc.
Angi Inc. (ANGI) Financial Performance & Income Statement Overview
Explore the financials of Angi Inc. (ANGI), including yearly and quarterly data on income, cash flow, and balance sheets.
Angi Inc. (ANGI) Income Statement & Financial Overview
Review Angi Inc. ANGI income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $245.91M | $267.87M | $296.72M | $315.13M |
| Cost of Revenue | $13.02M | $16.18M | $14.75M | $14.15M |
| Gross Profit | $232.90M | $251.69M | $281.97M | $300.98M |
| Gross Profit Ratio | $0.95 | $0.94 | $0.95 | $0.96 |
| R&D Expenses | $27.09M | $22.51M | $24.31M | $24.78M |
| SG&A Expenses | $175.86M | $204.10M | $232.27M | $242.69M |
| Operating Expenses | $212.90M | $249.53M | $274.15M | $267.47M |
| Total Costs & Expenses | $225.91M | $218.94M | $288.90M | $305.95M |
| Interest Income | $4.31M | $4.69M | $5.09M | $5.09M |
| Interest Expense | $5.04M | $5.04M | $5.04M | $5.04M |
| Depreciation & Amortization | $9.95M | $22.91M | $17.57M | $24.32M |
| EBITDA | $34.78M | $28.40M | $31.36M | $33.51M |
| EBITDA Ratio | $0.14 | $0.11 | $0.11 | $0.11 |
| Operating Income | $20.003M | $2.17M | $7.82M | $9.19M |
| Operating Income Ratio | $0.08 | $0.008 | $0.03 | $0.03 |
| Other Income/Expenses (Net) | -$216000.00 | -$1.72M | $934000.00 | -$471000.00 |
| Income Before Tax | $19.79M | $448000.00 | $8.75M | $8.72M |
| Income Before Tax Ratio | $0.08 | $0.002 | $0.03 | $0.03 |
| Income Tax Expense | $4.68M | $1.73M | -$26.61M | $4.63M |
| Net Income | $15.11M | -$1.29M | $35.16M | $3.76M |
| Net Income Ratio | $0.06 | -$0.005 | $0.12 | $0.01 |
| EPS | $0.03 | -$0.003 | $0.07 | $0.007 |
| Diluted EPS | $0.03 | -$0.003 | $0.07 | $0.007 |
| Weighted Avg Shares Outstanding | $50.35M | $49.78M | $49.85M | $50.16M |
| Weighted Avg Shares Outstanding (Diluted) | $50.35M | $49.78M | $50.70M | $50.70M |
Over the last four quarters, Angi Inc. achieved steady financial progress, growing revenue from $315.13M in Q2 2024 to $245.91M in Q1 2025. Gross profit stayed firm with margins at 95% in Q1 2025 versus 96% in Q2 2024. Operating income totaled $20.003M in Q1 2025, maintaining a 8% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $34.78M. Net income rose to $15.11M, with EPS at $0.03. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan